Metabolic Plasticity in Chemotherapy Resistance

Area of Science:

• Oncology
• Cancer Biology
• Metabolic Pathways

Background:

• Chemotherapy resistance is a major cause of cancer mortality.
• Cancer cells exhibit altered metabolism, utilizing various carbon sources beyond glucose.
• Tumor microenvironments create metabolic heterogeneity, impacting treatment response.

Purpose of the Study:

• To review known cancer metabolic profiles.
• To discuss studies on sensitizing tumors to chemotherapy via metabolic modulation.
• To explore the potential of metabolic modulators in overcoming drug resistance.

Main Methods:

• Literature review of cancer metabolic profiles.
• Analysis of studies investigating metabolic pathway modulation.
• Synthesis of findings on tumor sensitization to chemotherapy.

Main Results:

• Cancer cells reprogram their metabolism to support uncontrolled growth.
• Metabolic heterogeneity within tumors influences response to therapies.
• Modulating specific metabolic pathways can enhance chemotherapy sensitivity.

Conclusions:

• Understanding cancer metabolic dependencies is crucial for effective treatment.
• Targeting cancer metabolism presents a viable strategy to overcome chemotherapy resistance.
• Metabolic modulators hold promise for improving clinical outcomes in cancer therapy.